NCT03047226View on ClinicalTrials.gov

Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer

CompletedOBSERVATIONAL
Enrollment

311

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Lynch Syndrome
Interventions
OTHER

next-generation sequencing

Use next-generation sequencing to test germline mutation and microsatellite instability.

Trial Locations (7)

310009

YUANYING, Hangzhou

Unknown

Fujian Medical University Cancer Hospital, Fuzhou

Sun Yat-sen University Cancer Center, Guangzhou

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Yunnan Cancer Hospital, Kunming

Affiliated Hangzhou First People's Hospital, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
collaborator

Guangzhou Burning Rock Medical Examination Institute Co., Ltd.

INDUSTRY

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT03047226 - Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer | Biotech Hunter | Biotech Hunter